Idiopathic Pulmonary Fibrosis Nintomed is indicated for the treatment of idiopathic pulmonary fibrosis (IPF) in adults. Systemic Sclerosis-Associated Interstitial Lung Disease Nintomed is indicated to slow the rate of decline in pulmonary function in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD). Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype Nintomed is indicated in adults for the treatment of chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype.